Related Experiment Video
Updated: Jun 4, 2025

11:05
Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
Published on: January 7, 2019
9.4K
IRF7-deficient MDBK cell based on CRISPR/Cas9 technology for enhancing IBRV replication.
Guiyang Ge1, Dongli Li2, Qian Ling3
1College of Animal Science and Technology, Jilin Agricultural University, Changchun, China.
Frontiers in Microbiology
|December 18, 2024
Summary
Researchers developed IRF7-deleted MDBK cells to improve infectious bovine rhinotracheitis (IBR) vaccine production. These modified cells enhance bovine alphaherpesvirus-1 (BoAHV-1) replication, enabling the creation of higher-titer vaccines.
Area of Science:
- Veterinary Virology
- Cell Biology
- Immunology
Background:
- Infectious bovine rhinotracheitis (IBR), caused by bovine alphaherpesvirus-1 (BoAHV-1), is a significant cattle disease managed by vaccination.
- Madin-Darby bovine kidney (MDBK) cells are crucial for IBR vaccine production but are subject to innate immune gene inhibition of viral replication.
Purpose of the Study:
- To develop IRF7-deleted MDBK cells to enhance bovine alphaherpesvirus-1 (BoAHV-1) replication.
- To facilitate the production of high-titer infectious bovine rhinotracheitis (IBR) vaccines.
Main Methods:
- CRISPR/Cas9 technology was employed to knockout the IRF7 gene in MDBK cells.
- Virus growth curves, CCK-8 assays, cell scratch assays, and qPCR were used to assess viral replication and gene expression.
Main Results:
- IRF7 knockout in MDBK cells significantly increased IBRV replication capacity.
- A notable reduction in type I interferons (IFN-α and IFN-β) expression was observed in IRF7 knockout cells.
- The IRF7-/- MDBK cell lines demonstrated enhanced production of high-titer IBRV.
Conclusions:
- IRF7 knockout MDBK cell lines are effective for high-titer IBRV production.
- This advancement supports the development of more effective inactivated or attenuated IBR vaccines.
Related Concept Videos
CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
Homologous Recombination
50.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.2K

